- ►hematologylibrary.org [PDF] MA Dimopoulos, A Anagnostopoulos - Best Practice & Research Clinical Haematology, 2005 - Elsevier The diagnosis of Waldenström's macroglobulinemia (WM) requires evidence of
bone-marrow infiltration by lymphoplasmacytoid lymphoma and detection of serum
monoclonal protein of IgM type. The normal counterpart of the WM malignant ... Cited by 219 - Related articles - BL Direct - All 30 versions
- ►ascopubs.org [PDF] BD Cheson - Journal of Clinical Oncology, 1995 - jco.ascopubs.org Purpose: The purine analogs fludarabine, cladribine, an- -pentostatin are active
agents in the treatment of in- dolent lymphoid malignancies. This report reviews
the pattern, severity, and consequences of the immunosup- pression and ... Cited by 204 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org … P Panayiotidis, LA Moulopoulos, P Sfikakis … - Journal of Clinical Oncology, 2000 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the Departments of Clinical Therapeutics, Internal Medicine, ... Cited by 156 - Related articles - BL Direct - All 9 versions
- ►jcojournal.org [PDF] MA Dimopoulos, H Kantarjian, D Weber, S O' … - Journal of Clinical Oncology, 1994 - jcojournal.org Purpose: To assess the activity of 2-chlorodeoxyade- nosine (2CdA) as primary
therapy for patients with Wal- denstrim's macroglobulinemia. Patients and
Methods: 2CdA was given to 26 consec- utive, previously untreated and ... Cited by 97 - Related articles - BL Direct - All 6 versions
IM Ghobrial, MA Gertz, R Fonseca - Lancet Oncology, 2003 - Elsevier Waldenström macroglobulinemia (WM) is a lymphoid neoplasm characterised by a
monoclonal lymphoplasmacytic expansion accompanied by a serum monoclonal
immunoglobulin M (IgM). In some patients, the monoclonal protein will lead ... Cited by 94 - Related articles - All 9 versions
- ►jcojournal.org [PDF] T Facon, M Brouillard, A Duhamel, P Morel, M … - Journal of Clinical Oncology, 1993 - jcojournal.org Purpose: A single-center retrospective analysis was conducted in 167 patients
with Waldenstr6m's macro- globulinemia (WM) to delineate prognostic factors.
Patients and Methods: One hundred sixty-seven pa- tients diagnosed between ... Cited by 83 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org [PDF] JC Byrd, CA White, B Link, MS Lucas, WS … - Annals of Oncology, 1999 - Springer To assess the preliminary eĄcacy of rituximab therapy in Waldenstrom's
macroglobulinemia (WM), we examined the clinical and laboratory data for all
patients with WM treated on IDEC Pharmaceuticals sponsored trials and one ... Cited by 81 - Related articles - BL Direct - All 5 versions
- ►ascopubs.org [PDF] M Hoffman, MS Tallman, D Hakimian, D Janson … - Journal of Clinical Oncology, 1994 - jco.ascopubs.org Purpose: To determine the response rate to 2-chloro- deoxy-•denosine (2-CdA;
cladribine) in patients with ad- vanced indolent non-Hodgkin's lymphoma (NHL)
who fail to respond to or progress after a response to stan- dard ... Cited by 79 - Related articles - BL Direct - All 6 versions
- ►hematologylibrary.org - Free from Publisher P Morel, M Monconduit, D Jacomy, P Lenain, B … - Blood, 2000 - bloodjournal.hematologylibrary.org Waldenström macroglobulinemia (WM) is a clonal proliferation of lymphocytes or
plasma cells in bone marrow in which a large amount of monoclonal immunoglobulin
M (mIgM) protein is produced. 1 Clinical features include hyperviscosity, ... Cited by 74 - Related articles - BL Direct - All 4 versions
R Garcia-Sanz, S Montoto, A Torrequebrada, … - British journal of haematology, 2001 - interscience.wiley.com In this report we analyse the presenting features of a series of patients
diagnosed with Waldenström macroglobulinaemia (WM) in Spain over the last 10
years. Criteria for diagnosis required a serum monoclonal IgM protein 30 ... Cited by 68 - Related articles - BL Direct - All 5 versions
